Company Overview of Edge Therapeutics, Inc.
R. Loch MacDonald M.D., Ph.D.
Co-Founder, Chief Scientific Officer and Director, Edge Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 1 Board Members in 1 different organizations across 1 different industries.|
See Board Relationships
BackgroundDr. R. Loch MacDonald, M.D., Ph.D. co-founded Edge Therapeutics, Inc. in 2009 and serves as Chief Scientific Officer. Dr. Macdonald is widely considered as a top expert in the world on cerebral vasospasm. His 20 years of unrelenting research has led Edge Therapeutics to its first product, NimoGel, to cure vasospasm. Recent articles published by Dr. Macdonald are Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1), ...
Corporate Headquarters211 Warren Street
Newark, New Jersey 07103
Board Members Memberships
Co-Founder, Chief Scientific Officer and Director
University of Toronto
University Of Alberta
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Austin, TX | Publicis Touchpoint SolutionsPosted: May 21
- Fairfax, VA | Clinical Review GroupPosted: May 20